TrialFrontiers in cellular and infection microbiology2026

Gut microbial dynamics and antibiotic resistance during rifaximin therapy in severe cirrhosis: a ProPILA-Rifax ancillary study.

Ruben Ladeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.